Alliance for the Family Foundation, Philippines, Inc. v. Food and Drug Administration, G.R. No. 217872 (2017)
In 2016, the Supreme Court ordered the Food and Drug Administration (“FDA”) to observe the basic requirements of due process in the testing, evaluation, and approval of contraceptive drugs and devices, and to determine whether the contraceptives Implanon and Implanon NXT are abortifacients or non-abortifacients. A drug or device is an abortifacient if it is proven to primarily induce abortion, destroy a fetus inside the womb, or prevent the implantation of a fertilized ovum.